DUBLIN, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of three abstracts for presentation at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. Poster discussion and general poster presentations will occur on June 2 - 4 in Chicago, IL.
